Pain management varies among palliative care centers

November 5, 2012
Pain management varies among palliative care centers
The management of pain outcomes for terminally ill cancer patients varies widely between inpatient palliative care centers and is affected by organizational factors such as human resources adequacy, according to a study published in the Nov. 15 issue of Cancer.

(HealthDay)—The management of pain outcomes for terminally ill cancer patients varies widely between inpatient palliative care centers and is affected by organizational factors such as human resources adequacy, according to a study published in the Nov. 15 issue of Cancer.

In an effort to determine whether outcomes vary between centers, Dong Wook Shin, M.D., Dr.P.H., M.B.A., of the Seoul National University Hospital in South Korea, and colleagues conducted a study involving 1,711 patients with terminal cancer receiving care at 34 inpatient palliative care centers.

One week after admission the researchers found that 82.8 percent of patients had achieved adequate pain control, with a mean reduction of 0.69 to 1.91 points on pain scale scores. Pain management outcomes varied widely between palliative care centers. Human resource adequacy, in particular, correlated significantly with a greater reduction in and an achievement of adequate pain control.

"From the and research perspectives, we believe that more research is needed to identify organizational factors that affect pain management outcomes," the authors write. "Measures should be taken to reduce organizational factors that are associated with inadequate pain management."

Explore further: Inadequate pain meds in ER for patients with long-bone fractures

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Inadequate pain meds in ER for patients with long-bone fractures

May 21, 2012
(HealthDay) -- The majority of patients with long-bone fractures receive inadequate pain medication in the emergency department, and disparities in management exist, according to a study published in the May issue of the ...

Ketamine—an established cancer-pain drug—may do more harm than good

September 25, 2012
(Medical Xpress)—A drug which for decades has been widely used to treat pain related to cancer has no net clinical benefit, researchers in the Palliative Care Clinical Studies Collaborative (PaCCSC) based at Flinders University ...

A third of women with secondary breast cancer are needlessly living in pain, research shows

November 22, 2011
(Medical Xpress) -- New research released today by Breast Cancer Care and the University of Southampton reveals that more than a third (34 per cent) of women with secondary breast cancer are unnecessarily living with uncontrolled ...

Systematic pain management needed for children in ER

October 29, 2012
(HealthDay)—Steps to manage pain and stress in pediatric emergency medical care are recommended, according to a clinical report from the American Academy of Pediatrics (AAP) published online Oct. 29 in Pediatrics.

Better chronic pain management

August 15, 2011
Pain care management needs to be improved, with health care professionals committing to improve care as well as a retooling of the health care system to help people who are suffering, states an editorial in CMAJ (Canadian ...

Recommended for you

Scientists develop blood test that spots tumor-derived DNA in people with early-stage cancers

August 16, 2017
In a bid to detect cancers early and in a noninvasive way, scientists at the Johns Hopkins Kimmel Cancer Center report they have developed a test that spots tiny amounts of cancer-specific DNA in blood and have used it to ...

Toxic formaldehyde is produced inside our own cells, scientists discover

August 16, 2017
New research has revealed that some of the toxin formaldehyde in our bodies does not come from our environment - it is a by-product of an essential reaction inside our own cells. This could provide new targets for developing ...

Cell cycle-blocking drugs can shrink tumors by enlisting immune system in attack on cancer

August 16, 2017
In the brief time that drugs known as CDK4/6 inhibitors have been approved for the treatment of metastatic breast cancer, doctors have made a startling observation: in certain patients, the drugs—designed to halt cancer ...

Researchers find 'switch' that turns on immune cells' tumor-killing ability

August 16, 2017
Molecular biologists led by Leonid Pobezinsky and his wife and research collaborator Elena Pobezinskaya at the University of Massachusetts Amherst have published results that for the first time show how a microRNA molecule ...

Popular immunotherapy target turns out to have a surprising buddy

August 16, 2017
The majority of current cancer immunotherapies focus on PD-L1. This well studied protein turns out to be controlled by a partner, CMTM6, a previously unexplored molecule that is now suddenly also a potential therapeutic target. ...

A metabolic treatment for pancreatic cancer?

August 15, 2017
Pancreatic cancer is now the third leading cause of cancer mortality. Its incidence is increasing in parallel with the population increase in obesity, and its five-year survival rate still hovers at just 8 to 9 percent. Research ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.